BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 6355070)

  • 1. Opiate withdrawal using lofexidine, a clonidine analogue with fewer side effects.
    Washton AM; Resnick RB; Geyer G
    J Clin Psychiatry; 1983 Sep; 44(9):335-7. PubMed ID: 6355070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outpatient opiate detoxification with clonidine.
    Washton AM; Resnick RB
    J Clin Psychiatry; 1982 Jun; 43(6 Pt 2):39-41. PubMed ID: 7085584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lofexidine, an {alpha}2-receptor agonist for opioid detoxification.
    Gish EC; Miller JL; Honey BL; Johnson PN
    Ann Pharmacother; 2010 Feb; 44(2):343-51. PubMed ID: 20040696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lofexidine blocks acute opiate withdrawal.
    Gold MS; Pottash AC; Sweeney DR; Extein I; Annitto WJ
    NIDA Res Monogr; 1982 Apr; 41():264-8. PubMed ID: 6811917
    [No Abstract]   [Full Text] [Related]  

  • 5. Opiate withdrawal using clonidine. A safe, effective, and rapid nonopiate treatment.
    Gold MS; Pottash AC; Sweeney DR; Kleber HD
    JAMA; 1980 Jan; 243(4):343-6. PubMed ID: 7351747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opiate detoxification using lofexidine.
    Washton AM; Resnick RB; Perzel JF; Garwood J
    NIDA Res Monogr; 1982 Apr; 41():261-3. PubMed ID: 6811916
    [No Abstract]   [Full Text] [Related]  

  • 7. Double-blind study of lofexidine and clonidine in the detoxification of opiate addicts in hospital.
    Kahn A; Mumford JP; Rogers GA; Beckford H
    Drug Alcohol Depend; 1997 Jan; 44(1):57-61. PubMed ID: 9031821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clonidine in opiate withdrawal: review and appraisal of clinical findings.
    Washton AM; Resnick RB
    Pharmacotherapy; 1981; 1(2):140-6. PubMed ID: 6765486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lofexidine for opiate detoxification: review of recent randomised and open controlled trials.
    Strang J; Bearn J; Gossop M
    Am J Addict; 1999; 8(4):337-48. PubMed ID: 10598217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early clinical studies of levo-alpha acetylmethadol (LAAM): an opiate for use in the medical treatment of chronic heroin dependence.
    Blaine JD
    NIDA Res Monogr; 1978; (19):249-59. PubMed ID: 106289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alphaâ‚‚-adrenergic agonists for the management of opioid withdrawal.
    Gowing L; Farrell M; Ali R; White JM
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD002024. PubMed ID: 27140827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-patient detoxification procedures, treatment retention, and post-treatment opiate use: comparison of lofexidine + naloxone, lofexidine + placebo, and methadone.
    McCambridge J; Gossop M; Beswick T; Best D; Bearn J; Rees S; Strang J
    Drug Alcohol Depend; 2007 Apr; 88(1):91-5. PubMed ID: 17064857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomised double-blind comparison of lofexidine and clonidine in the out-patient treatment of opiate withdrawal.
    Carnwath T; Hardman J
    Drug Alcohol Depend; 1998 May; 50(3):251-4. PubMed ID: 9649979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of clonidine on opiate withdrawal symptoms. Results - biochemical mechanisms (author's transl)].
    Girard M; Escande M; Granier F; Gardes JP
    Encephale; 1982; 8(1):37-48. PubMed ID: 6284474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in opiate detoxification: clonidine and lofexidine.
    Washton AM; Resnick RB
    NIDA Res Monogr; 1983 Apr; 43():44-50. PubMed ID: 6410276
    [No Abstract]   [Full Text] [Related]  

  • 16. Opiate addiction and the locus coeruleus. The clinical utility of clonidine, naltrexone, methadone, and buprenorphine.
    Gold MS
    Psychiatr Clin North Am; 1993 Mar; 16(1):61-73. PubMed ID: 8456048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accelerated lofexidine treatment regimen compared with conventional lofexidine and methadone treatment for in-patient opiate detoxification.
    Bearn J; Gossop M; Strang J
    Drug Alcohol Depend; 1998 May; 50(3):227-32. PubMed ID: 9649976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relative potency of levo-alpha-acetylmethadol and methadone in humans under acute dosing conditions.
    Eissenberg T; Stitzer ML; Bigelow GE; Buchhalter AR; Walsh SL
    J Pharmacol Exp Ther; 1999 May; 289(2):936-45. PubMed ID: 10215673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naltrexone and lofexidine combination treatment compared with conventional lofexidine treatment for in-patient opiate detoxification.
    Buntwal N; Bearn J; Gossop M; Strang J
    Drug Alcohol Depend; 2000 May; 59(2):183-8. PubMed ID: 10891632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, open-label trial comparing methadone and Levo-Alpha-Acetylmethadol (LAAM) in maintenance treatment of opioid addiction.
    Wolstein J; Gastpar M; Finkbeiner T; Heinrich C; Heitkamp R; Poehlke T; Scherbaum N
    Pharmacopsychiatry; 2009 Jan; 42(1):1-8. PubMed ID: 19153939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.